19 results
At the PTAB Blog
Federal Circuit Disinfects PTAB’s Obviousness Finding for MRSA Inactivation Patent Federal Circuit Disinfects PTAB’s Obviousness Finding for MRSA Inactivation Patent
November 29, 2021
Articles
Patenting Antibody Combination Therapies Patenting Antibody Combination Therapies
December 3, 2020
Antibody TherapeuticsIP Health Blog
FDA Guidance on Acceptance Review for De Novo Classification Requests FDA Guidance on Acceptance Review for De Novo Classification Requests
September 30, 2019
IP Health Blog
FDA Final Guidance on Postmarketing Safety Reporting for Combination Products FDA Final Guidance on Postmarketing Safety Reporting for Combination Products
July 29, 2019
Event
BIO Asia-Taiwan International Conference and Exhibition BIO Asia-Taiwan International Conference and Exhibition
July 24-28, 2019
Taipei
IP Health Blog
FDA Commissioner Statement about the Orange Book FDA Commissioner Statement about the Orange Book
February 7, 2019
IP Health Blog
USPTO Issues Memorandum on Recent Subject Matter Eligibility Decision: Vanda Pharm. Inc. v. West-Ward Pharm. USPTO Issues Memorandum on Recent Subject Matter Eligibility Decision: Vanda Pharm. Inc. v. West-Ward Pharm.
August 1, 2018
IP Health Blog
FDA Draft Guidance on Multiple Function Device Products FDA Draft Guidance on Multiple Function Device Products
May 3, 2018
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.